BioLineRx (BLRX) Short Interest Ratio & Short Volume $3.57 -0.65 (-15.32%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$3.58 +0.01 (+0.25%) As of 01/30/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends BioLineRx Short Interest DataBioLineRx (BLRX) has a short interest of 1.26 million shares. This marks a 53.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 578,569 shares to cover all short positions.Current Short Interest1,260,000 sharesPrevious Short Interest822,200 sharesChange Vs. Previous Month+53.25%Dollar Volume Sold Short$5.27 millionShort Interest Ratio0.2 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares79,940,000 sharesPercentage of Shares Shorted1.58%Today's Trading Volume706,508 sharesAverage Trading Volume578,569 sharesToday's Volume Vs. Average122% Short Selling BioLineRx? Sign up to receive the latest short interest report for BioLineRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLRX Short Interest Over TimeBLRX Days to Cover Over TimeBLRX Percentage of Float Shorted Over Time BioLineRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20251,260,000 shares $5.27 million +53.3%N/A0.2 $4.18 12/31/2024822,200 shares $175,950.80 -0.7%N/A0.2 $0.21 12/15/2024827,800 shares $186,172.22 -10.2%N/A0.8 $0.22 11/30/2024921,900 shares $276,570.00 -16.2%N/A1.1 $0.30 11/15/20241,100,000 shares $523,160.00 +3.8%N/A1.6 $0.48 10/31/20241,060,000 shares $434,600.00 +70.6%N/A3.5 $0.41 10/15/2024621,400 shares $271,924.64 +351.3%N/A2.2 $0.44 9/30/2024137,700 shares $73,820.97 -23.2%N/A0.5 $0.54 9/15/2024179,200 shares $111,301.12 +28.7%N/A0.7 $0.62 8/31/2024139,200 shares $90,048.48 -47.9%N/A0.5 $0.65 Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024267,200 shares $181,241.76 -3.3%N/A0.8 $0.68 7/31/2024276,400 shares $217,084.56 +130.9%N/A0.8 $0.79 7/15/2024119,700 shares $90,972.00 -63.1%N/A0.3 $0.76 6/30/2024324,300 shares $184,818.57 +52.9%N/A0.9 $0.57 6/15/2024212,100 shares $141,661.59 -40.5%N/A0.5 $0.67 5/31/2024356,200 shares $265,582.72 +62.6%N/A0.8 $0.75 5/15/2024219,100 shares $135,173.75 -46.6%N/A0.5 $0.62 4/30/2024410,600 shares $274,855.64 -47.6%N/A1 $0.67 4/15/2024783,600 shares $504,560.04 +32.5%N/A1.8 $0.64 3/31/2024591,500 shares $662,480.00 +82.2%N/A1.6 $1.12 3/15/2024324,700 shares $373,405.00 +76.6%N/A1 $1.15 2/29/2024183,900 shares $244,587.00 -8.1%N/A0.6 $1.33 2/15/2024200,000 shares $221,000.00 -19.7%N/A0.7 $1.11 1/31/2024249,100 shares $296,429.00 -4.7%N/A0.8 $1.19 1/15/2024261,500 shares $368,715.00 +16.1%N/A0.8 $1.41 12/31/2023225,200 shares $353,564.00 +96.2%N/A0.6 $1.57 12/15/2023114,800 shares $182,532.00 -59.2%N/A0.3 $1.59 11/30/2023281,100 shares $407,595.00 -21.3%N/A0.3 $1.45 11/15/2023357,300 shares $603,837.00 -27.2%N/A0.3 $1.69 10/31/2023490,600 shares $735,900.00 -52.4%N/A0.4 $1.50 10/15/20231,030,000 shares $1.65 million -59.8%N/A0.9 $1.60 9/30/20232,560,000 shares $4.66 million -42.7%N/A2.2 $1.82 9/15/20234,470,000 shares $8.72 million +86.3%N/A4.1 $1.95 8/31/20232,400,000 shares $4.20 million +2.6%N/A2.6 $1.75 8/15/20232,340,000 shares $3.49 million +9.9%N/A6.2 $1.49 7/31/20232,130,000 shares $3.28 million -14.8%N/A4.9 $1.54 7/15/20232,500,000 shares $4.18 million +8.2%N/A5.6 $1.67 6/30/20232,310,000 shares $3.68 million +0.9%N/A4.9 $1.60 6/15/20232,290,000 shares $4.05 million +19.3%N/A4.6 $1.77 5/31/20231,920,000 shares $3.02 million -1.5%N/A3.8 $1.58Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 5/15/20231,950,000 shares $2.69 million +69.6%N/A4 $1.38 4/30/20231,150,000 shares $1.23 million +21.3%N/A3.1 $1.07 4/15/2023948,300 shares $1.04 million +70.6%N/A2.8 $1.10 3/31/2023556,000 shares $492,894.00 +546.5%N/A1.8 $0.89 3/15/202386,000 shares $52,374.00 +9.7%N/A0.3 $0.61 2/28/202378,400 shares $46,648.00 -64.7%N/A0.3 $0.60 2/15/2023222,100 shares $137,702.00 +97.3%N/A0.9 $0.62 1/31/2023112,600 shares $70,926.74 -42.1%N/A0.3 $0.63 1/15/2023194,600 shares $134,488.06 +9.8%N/A0.6 $0.69 12/30/2022177,200 shares $104,548.00 +22.6%N/A0.5 $0.59 12/15/2022144,500 shares $92,248.80 -11.1%N/A0.4 $0.64 11/30/2022162,500 shares $114,546.25 -37.6%N/A0.4 $0.70 11/15/2022260,200 shares $176,936.00 +7.3%N/A0.7 $0.68 10/31/2022242,500 shares $205,446.00 +33.4%N/A0.9 $0.85 10/15/2022181,800 shares $152,712.00 +127.8%N/A0.7 $0.84 9/30/202279,800 shares $73,815.00 -80.5%N/A0.3 $0.93 9/15/2022408,300 shares $649,197.00 +17.3%N/A1.9 $1.59 8/31/2022348,200 shares $529,264.00 -20.7%N/A2.7 $1.52 8/15/2022439,000 shares $838,490.00 +14.3%N/A3.5 $1.91 7/31/2022384,000 shares $506,880.00 -6.6%N/A2.8 $1.32 7/15/2022411,200 shares $551,008.00 +14.8%N/A2.7 $1.34 6/30/2022358,100 shares $458,368.00 +3.7%N/A2.2 $1.28 6/15/2022345,400 shares $466,290.00 -18.1%N/A2 $1.35 5/31/2022421,800 shares $658,008.00 -11.7%N/A2.3 $1.56 5/15/2022477,400 shares $572,880.00 +30.8%N/A2.3 $1.20 4/30/2022365,000 shares $445,300.00 -9.5%N/A1.8 $1.22 4/15/2022403,300 shares $621,082.00 -20.8%N/A2 $1.54 3/31/2022509,200 shares $870,732.00 -11.3%N/A2.1 $1.71 3/15/2022574,100 shares $878,373.00 +14.7%N/A2 $1.53 2/28/2022500,700 shares $761,064.00 -6.1%N/A1.2 $1.52 2/15/2022533,400 shares $938,784.00 +25.9%N/A1.2 $1.76 1/31/2022423,800 shares $771,316.00 +6.5%N/A0.9 $1.82 1/15/2022398,100 shares $800,181.00 +21.4%N/A0.9 $2.01 12/31/2021328,000 shares $669,120.00 +19.5%N/A0.6 $2.04 12/15/2021274,600 shares $648,056.00 +135.3%N/A0.6 $2.36 11/30/2021116,700 shares $306,921.00 -36.8%N/A0.3 $2.63 11/15/2021184,500 shares $527,670.00 +18.0%N/A0.5 $2.86 10/29/2021156,400 shares $444,176.00 -54.1%N/A0.4 $2.84 10/15/2021340,700 shares $1.04 million +65.3%N/A0.8 $3.06 9/30/2021206,100 shares $566,775.00 +8.5%N/A0.4 $2.75 9/15/2021190,000 shares $513,000.00 -34.7%N/A0.2 $2.70 8/31/2021291,000 shares $835,170.00 +5.0%N/A0.3 $2.87 8/13/2021277,100 shares $836,842.00 +3.2%N/A0.3 $3.02 7/30/2021268,500 shares $867,255.00 +228.2%N/A0.2 $3.23 7/15/202181,800 shares $273,212.00 -27.2%N/A0 $3.34 6/30/2021112,300 shares $315,563.00 -64.8%N/A0 $2.81 6/15/2021319,100 shares $890,289.00 -50.7%N/A0.1 $2.79 5/28/2021647,600 shares $1.85 million +15.8%N/A0.1 $2.86 5/14/2021559,500 shares $1.59 million +27.6%N/A0.1 $2.85 4/30/2021438,500 shares $1.34 million +9.3%N/A0.1 $3.05Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 4/15/2021401,200 shares $1.10 million -3.0%N/A0.3 $2.73 3/31/2021413,400 shares $1.17 million -7.0%N/A0.2 $2.82 3/15/2021444,600 shares $1.35 million -34.2%N/A0.2 $3.03 2/26/2021675,400 shares $2.18 million -62.5%N/A0.3 $3.23 2/12/20211,800,000 shares $6.68 million +0.6%N/A0.7 $3.71 1/29/20211,790,000 shares $5.24 million -27.8%N/A0.7 $2.93 1/15/20212,480,000 shares $6.94 million +0.8%N/A0.4 $2.80 12/31/20202,460,000 shares $6.27 million -2.4%N/A0.4 $2.55 12/15/20202,520,000 shares $8.54 million +11.5%N/A0.5 $3.39 11/30/20202,260,000 shares $5.24 million -8.9%N/A0.5 $2.32 11/15/20202,480,000 shares $5.83 million +79.7%N/A0.5 $2.35 10/30/20201,380,000 shares $2.04 million -8.0%N/A0.3 $1.48 10/15/20201,500,000 shares $2.41 million No ChangeN/A6.1 $1.61 9/30/20201,500,000 shares $2.46 million -1.3%N/A4.5 $1.64 9/15/20201,520,000 shares $2.64 million -1.3%N/A4.2 $1.74 8/31/20201,540,000 shares $2.80 million -7.2%N/A3.5 $1.82 8/14/20201,660,000 shares $3.40 million +12.2%N/A2.3 $2.05 7/31/20201,480,000 shares $3.36 million +114.6%N/A2.1 $2.27 7/15/2020689,800 shares $1.22 million +60.2%N/A1.1 $1.77 6/30/2020430,600 shares $736,326.00 +7.3%N/A0.8 $1.71 6/15/2020401,200 shares $649,944.00 +432.8%N/A0.8 $1.62 5/29/202075,300 shares $146,082.00 +2.5%N/A0.2 $1.94 5/15/202073,500 shares $118,335.00 +25.6%N/A0.4 $1.61 4/30/202058,500 shares $98,280.00 -5.8%N/A0.9 $1.68 4/15/202062,100 shares $108,414.18 +37.4%N/A0.9 $1.75 3/31/202045,200 shares $71,416.00 -14.7%N/A0.6 $1.58 3/13/202053,000 shares $89,570.00 -19.7%N/A1.1 $1.69 2/28/202066,000 shares $77,880.00 -9.1%N/A0.4 $1.18 2/14/202072,600 shares $125,598.00 -51.0%N/A0.4 $1.73 1/31/2020148,200 shares $271,206.00 -34.9%N/A0.8 $1.83 BLRX Short Interest - Frequently Asked Questions What is BioLineRx's current short interest? Short interest is the volume of BioLineRx shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 1,260,000 shares of BLRX short. Learn More on BioLineRx's current short interest. Is BioLineRx's short interest increasing or decreasing? BioLineRx saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 1,260,000 shares, an increase of 53.2% from the previous total of 822,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioLineRx's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioLineRx: Verrica Pharmaceuticals Inc. (3.99%), RenovoRx, Inc. (0.55%), BioVie Inc. (9.57%), Coeptis Therapeutics Holdings, Inc. (3.98%), Xilio Therapeutics, Inc. (1.08%), Cognition Therapeutics, Inc. (1.77%), Exicure, Inc. (11.54%), Lexaria Bioscience Corp. (4.54%), Chemomab Therapeutics Ltd. (0.45%), Marinus Pharmaceuticals, Inc. (4.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short BioLineRx stock? Short selling BLRX is an investing strategy that aims to generate trading profit from BioLineRx as its price is falling. BLRX shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioLineRx? A short squeeze for BioLineRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLRX, which in turn drives the price of the stock up even further. How often is BioLineRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLRX, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies VRCA Short Interest RNXT Short Interest BIVI Short Interest COEP Short Interest XLO Short Interest CGTX Short Interest XCUR Short Interest LEXX Short Interest CMMB Short Interest MRNS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLRX) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
